Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report
- PMID: 31031662
- PMCID: PMC6470279
- DOI: 10.3389/fpsyt.2019.00236
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report
Abstract
Background: Many evidences have demonstrated the effectiveness of cognitive remediation on cognition and functioning in patients with schizophrenia. Some researchers speculate that cognitive deficits are more amenable to remediation during earlier phases of illness than in chronicity. Therefore, cognitive rehabilitation should be used as an early intervention, seeking to produce durable functional changes in the early course of schizophrenia. Although there is strong evidence that cognitive remediation is effective in adult schizophrenia, there is little evidence about its efficacy and long-term generalized effectiveness in the early course of the disease. In this paper, we intended to investigate the possibility that cognitive remediation may produce more beneficial effects when applied in the early phase of the illness compared to chronic patients. Materials and methods: Data were gathered from a database used for a previous study performed by our group, in which 56 patients with schizophrenia received a cognitive remediation intervention. In a post hoc analysis, patients with a duration of illness shorter than 5 years were defined as "early course" patients, while patients with a duration of illness longer than 5 years were defined as "chronic." Clinical, neuropsychological, and functional outcome variables were assessed at baseline and after treatment. Result: Of the 56 patients included in the study, 11 were "early course" and 45 were "chronic." Both the early course group and the chronic group showed significant improvements in all the clinical, neurocognitive, and functional parameters analyzed. A significantly greater improvement in early course patients compared with chronic patients emerged in clinical and functional measures. No differential change was observed between early course patients and chronic patients in the cognitive composite score. Conclusion: Our study confirms the effectiveness of cognitive remediation in improving clinical, cognitive, and functional parameters in patients with schizophrenia, both in patients in the early course and in chronic patients. However, patients in the early course showed a differential, greater change in clinical and functional parameters compared to chronic patients. Although this study has some limitations, it confirms the effectiveness of cognitive remediation interventions, particularly if applied in the early course of the illness.
Keywords: cognitive remediation; early course; effectiveness; schizophrenia; social function.
Similar articles
-
Cognitive remediation in the early course of schizophrenia: a critical review.Curr Pharm Des. 2012;18(4):534-41. doi: 10.2174/138161212799316091. Curr Pharm Des. 2012. PMID: 22239585 Review.
-
Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long-term course of illness.Early Interv Psychiatry. 2014 Feb;8(1):32-8. doi: 10.1111/eip.12029. Epub 2013 Jan 24. Early Interv Psychiatry. 2014. PMID: 23343011 Clinical Trial.
-
Predictors of cognitive and functional improvement and normalization after cognitive remediation in patients with schizophrenia.Schizophr Res. 2013 Oct;150(1):51-7. doi: 10.1016/j.schres.2013.08.011. Epub 2013 Aug 30. Schizophr Res. 2013. PMID: 23998953
-
Assessment of a six-week computer-based remediation program for social cognition in chronic schizophrenia.Shanghai Arch Psychiatry. 2015 Oct;27(5):296-306. doi: 10.11919/j.issn.1002-0829.215095. Shanghai Arch Psychiatry. 2015. PMID: 26977127 Free PMC article.
-
[First-episode psychosis, cognitive difficulties and remediation].Encephale. 2013 Sep;39 Suppl 2:S83-92. doi: 10.1016/S0013-7006(13)70101-5. Encephale. 2013. PMID: 24084427 Review. French.
Cited by
-
Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes.Contemp Clin Trials Commun. 2024 Jul 25;41:101337. doi: 10.1016/j.conctc.2024.101337. eCollection 2024 Oct. Contemp Clin Trials Commun. 2024. PMID: 39205914 Free PMC article.
-
Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients.Transl Psychiatry. 2020 May 12;10(1):136. doi: 10.1038/s41398-020-0828-4. Transl Psychiatry. 2020. PMID: 32398765 Free PMC article.
-
A Short Course Computer-assisted Cognitive Remediation in Patients with Schizophrenia Spectrum Disorders: A Randomized Clinical Trial.Basic Clin Neurosci. 2021 Jul-Aug;12(4):551-562. doi: 10.32598/bcn.2021.3112.1. Epub 2021 Jul 1. Basic Clin Neurosci. 2021. PMID: 35154595 Free PMC article.
-
Confirmatory Efficacy of Cognitive Enhancement Therapy for Early Schizophrenia: Results From a Multisite Randomized Trial.Psychiatr Serv. 2022 May;73(5):501-509. doi: 10.1176/appi.ps.202000552. Epub 2021 Sep 2. Psychiatr Serv. 2022. PMID: 34470506 Free PMC article. Clinical Trial.
-
Modelling associations between neurocognition and functional course in young people with emerging mental disorders: a longitudinal cohort study.Transl Psychiatry. 2020 Jan 21;10(1):22. doi: 10.1038/s41398-020-0726-9. Transl Psychiatry. 2020. PMID: 32066687 Free PMC article.
References
LinkOut - more resources
Full Text Sources